Advertisement Biogen Idec names new EVP of business development - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biogen Idec names new EVP of business development

Biogen Idec, a biologics manufacturing company, has appointed Michael Lytton as its new executive vice president of business and corporate development.

In this position, Mr Lytton will be responsible for leading the company’s business development activities. From 2001 to 2009, Mr Lytton served as a general partner at Oxford Bioscience Partners, a venture capital firm.

Hans Hasler, COO of Biogen Idec, said: “Michael brings more than 25 years of business development, investment and legal experience in the biotechnology industry. His M&A background, as well as his experience in identifying and translating promising science into successful companies, makes him uniquely qualified to build on our track record of highly disciplined and productive business development.”